---
trial_id: 172
discovery_date: 2022-03-20 17:40:26.671386
date: 2022-03-20 17:40:26.671386
title: "Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study"
summary: |
  <b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Ofatumumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05285904?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-03-18 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Ofatumumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>